These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36855936)

  • 1. Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia.
    Yang YT; Yao CY; Chiu PJ; Kao CJ; Hou HA; Lin CC; Chou WC; Tien HF
    Am J Hematol; 2023 May; 98(5):784-793. PubMed ID: 36855936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
    Jin P; Tan Y; Zhang W; Li J; Wang K
    Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.
    Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD
    Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia.
    Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ
    J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia.
    Anande G; Deshpande NP; Mareschal S; Batcha AMN; Hampton HR; Herold T; Lehmann S; Wilkins MR; Wong JWH; Unnikrishnan A; Pimanda JE
    Clin Cancer Res; 2020 Jul; 26(14):3597-3607. PubMed ID: 32122925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Alternative Splicing Events on Acute Myeloid Leukemia.
    Chen SL; Dai YJ; Hu F; Wang Y; Li H; Liang Y
    DNA Cell Biol; 2020 Nov; 39(11):2040-2051. PubMed ID: 32915082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases.
    Xie ZC; Gao L; Chen G; Ma J; Yang LH; He RQ; Li MW; Cai KT; Li TT; Peng ZG
    Neoplasma; 2020 May; 67(3):623-635. PubMed ID: 32039631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
    Zhang B; Yang L; Wang X; Fu D
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-Seq profiling reveals aberrant RNA splicing in patient with adult acute myeloid leukemia during treatment.
    Li XY; Yao X; Li SN; Suo AL; Ruan ZP; Liang X; Kong Y; Zhang WG; Yao Y
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1426-33. PubMed ID: 24867525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
    Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
    Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
    BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.
    Hou HA; Liu CY; Kuo YY; Chou WC; Tsai CH; Lin CC; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Tien HF
    Oncotarget; 2016 Feb; 7(8):9084-101. PubMed ID: 26812887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia.
    Liu J; Huang B; Xiao Y; Xiong HM; Li J; Feng DQ; Chen XM; Zhang HB; Wang XZ
    Onkologie; 2012; 35(6):335-40. PubMed ID: 22722453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
    He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
    Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy.
    Zhang QX; Pan YM; Xiao HL; An N; Deng SS; Du X
    Neoplasma; 2022 Sep; 69(5):1198-1208. PubMed ID: 36131606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Characterization of the Prognosis Value of Alternative Splicing Events in Acute Myeloid Leukemia.
    Chen XX; Zhu JH; Li ZP; Xiao HT; Zhou H
    DNA Cell Biol; 2020 Jul; 39(7):1243-1255. PubMed ID: 32543226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy.
    Yang YT; Yao CY; Kao CJ; Chiu PJ; Lin ME; Hou HA; Lin CC; Chou WC; Tien HF
    Br J Haematol; 2024 Nov; 205(5):1751-1764. PubMed ID: 39192759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia.
    Rivera OD; Mallory MJ; Quesnel-Vallières M; Chatrikhi R; Schultz DC; Carroll M; Barash Y; Cherry S; Lynch KW
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia.
    Chen Z; Song J; Wang W; Bai J; Zhang Y; Shi J; Bai J; Zhou Y
    Am J Hematol; 2021 Nov; 96(11):1385-1395. PubMed ID: 34339537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
    Orsmark-Pietras C; Landberg N; Lorenz F; Uggla B; Höglund M; Lehmann S; Derolf Å; Deneberg S; Antunovic P; Cammenga J; Möllgård L; Wennström L; Lilljebjörn H; Rissler M; Fioretos T; Lazarevic VL
    Genes Chromosomes Cancer; 2021 Jun; 60(6):426-433. PubMed ID: 33433047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.